Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
Published on: November 29, 2024
MicroRNA-based therapeutics in central nervous system injuries
Ping Sun1, Da Zhi Liu2, Glen C Jickling3
11 Department of Neurology, Pittsburgh Institute of Brain Disorders & Recovery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
MicroRNAs (miRNAs) show promise as therapeutic targets for central nervous system (CNS) injuries like stroke and TBI. This review explores miRNA-based treatments, delivery methods, and mechanisms for CNS repair.
Area of Science:
- Neuroscience
- Molecular Biology
- Biotechnology
Background:
- Central nervous system (CNS) injuries, including stroke, traumatic brain injury (TBI), and spinal cord injury (SCI), are leading causes of mortality and disability.
- MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are emerging as critical diagnostic biomarkers and therapeutic targets for CNS disorders.
- Current therapeutic strategies for CNS injuries are limited, necessitating the exploration of novel treatment modalities.
Purpose of the Study:
- To review the current applications of miRNA-based therapeutics for stroke, TBI, and SCI.
- To discuss the administration methods, optimal timing, and dosage for effective miRNA delivery into the CNS.
- To elucidate the underlying mechanisms of miRNA-based therapies and present potential pharmacological agents.
Main Methods:
- Literature review of current research on miRNA-based therapeutics for CNS injuries.
- Analysis of administration routes, delivery systems, and pharmacokinetic considerations for miRNA drugs.
- Examination of molecular mechanisms, including modulation of oxidative stress, inflammation, apoptosis, and promotion of neurogenesis and angiogenesis.
Main Results:
- miRNA mimics and inhibitors (antagomiRs) offer potential for modulating gene expression in CNS injury models.
- Effective delivery of miRNA therapeutics to the CNS remains a challenge, requiring optimized administration strategies and time windows.
- miRNA-based therapies target key pathways involved in CNS injury, such as inflammation, apoptosis, and neurogenesis.
Conclusions:
- miRNA-based therapies hold significant therapeutic potential for CNS injuries like stroke, TBI, and SCI.
- Further research is needed to overcome delivery challenges and fully realize the clinical application of miRNA therapeutics.
- Targeting specific miRNAs presents a promising avenue for developing novel pharmacological agents to protect against CNS damage and promote recovery.
Related Concept Videos
MicroRNAs
MicroRNAs
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
What is a Nervous System?
The Parasympathetic Nervous System
The Sympathetic Nervous System

